يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"хориоидальная неоваскулярная мембрана"', وقت الاستعلام: 0.33s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Ophthalmology in Russia; Том 16, № 1S (2019); 79-84 ; Офтальмология; Том 16, № 1S (2019); 79-84 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2017-6

    وصف الملف: application/pdf

    Relation: https://www.ophthalmojournal.com/opht/article/view/902/586; Катаргина Л.А., Денисова Е.В., Рябцев Д.И. Болезнь Беста: клиническое наблюдение семейного случая. Российская педиатрическая офтальмология. 2015;10(2):15–19.; Marmorstein A.D., Kinnick T.R., Stanton J.B., Johnson A.A., Lynch R.M., Marmorstein L.Y. Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium. Molecular Vision. 2015;21:347–59.; Gass J.M.D. Best’s disease. In: Stereoscopic Atlas of Macular Disease. Diagnosis and Treatment. St. Louis-London-Philadelphia-Sydney-Toronto: Mosby; 1997:304–313.; Parodi M.B., Iacono P., Campa C., Turco C., Bandello F. Fundus autofluorescence patterns in Best vitelliform macular dystrophy. Am. J. Ophthalmol. 2014;158:1086–1092. DOI:10.1016 / j.ajo.2014.07.026; Chhablani J., Jalali S. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child. Eur. J. Ophthalmol. 2012;22(4):677–679. DOI:10.5301/ejo.5000095; Elkhoyaali A., Chatoui S., Bercheq N., Elouatassi N., Zerrouk R., Elasri F., Reda K., Oubaaz A. Choroidal neovascularization complicating Best’s vitelliform macular dystrophy in a child. J. Fr. Ophtalmol. 2016;39(1):69–73. DOI:10.1016/j.jfo.2015.05.008 (In French).; Leu J., Schrage N.F., Degenring R.F. Choroidal neovascularisation secondary to Best’s disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefes Arch. Clin. Exp. Ophthalmol. 2007;245(11):1723–1725. DOI: 10,1007 / s00417-007-0604-7; Schatz P., Sharon D., Al-Hamdani S., Andréasson S., Larsen M. Retinal structure in young patients aged 10 years or less with Best vitelliform macular dystrophy. Graefes Arch. Clin. Exp. Ophthalmol. 2016;254(2):215–221. DOI:10.1007/s00417-015-3025-z; Duncker T., Greenberg J.P., Ramachandran R., Hood D.C., Smith R.T., Hirose T., Woods R.L., Tsang S.H., Delori F.C., Sparrow J.R. Quantitative Fundus Autofluorescence and Optical Coherence Tomography in Best Vitelliform Macular Dystrophy. Invest. Ophthalmol. Vis. Sci. 2014;55(3):1471–1482. DOI:10.1167/iovs.13-13834; Sulzbacher F., Pollreisz A., Kaider A., Kickinger S., et al. Identification and clinical role of choroidal neovascularization characteristics based on optical coherence tomography angiography. Acta Ophthalmol. 2017;95(4):414–420. DOI:10.1111/aos.13364; https://www.ophthalmojournal.com/opht/article/view/902

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7